Original Research

Published on 01 Feb 2023

Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation

in Cancer Endocrinology

Fuqiang Zhao
Liling Huang
Zhijie Wang
Fangze Wei
Tixian Xiao
Qian Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1061187

3,089 views
6 citations

Original Research

Published on 31 Jan 2023

A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort

in Cancer Endocrinology

Gouling Zhan
Honghua Peng
Lehong Zhou
Long Jin
Xueyi Xie
Yu He
Xuan Wang
Zhangyan Du
Peiguo Cao

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1070396

2,995 views
6 citations

Original Research

Published on 30 Jan 2023

A novel pyroptosis gene expression-based risk score for survival in gastric cancer

in Cancer Endocrinology

Jiali Hu
Yang Song
Xintian Cai
Halike Halina
Kun Qiao
Jiajie Lu
Chengliang Yin
Feng Gao

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1120216

3,387 views
8 citations

Original Research

Published on 30 Jan 2023

Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis

in Cancer Endocrinology

Ivana Puliafito
Federico Chillari
Alessandro Russo
Ornella Cantale
Dorotea Sciacca
Luigi Castorina
Cristina Colarossi
Tindara Franchina
Maria Paola Vitale
Giuseppina Rosaria Rita Ricciardi

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1065599

2,061 views
2 citations

Original Research

Published on 30 Jan 2023

Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma

in Cancer Endocrinology

Zhihuai Wang
Peng Gao
Weijun Sun
Adeel ur Rehman
Jiakai Jiang
Suobao Xu
Cailin Xue
Chunfu Zhu
Xihu Qin

Frontiers in Endocrinology

doi 10.3389/fendo.2023.938102

2,623 views
4 citations

Original Research

Published on 30 Jan 2023

Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets

in Cancer Endocrinology

Yongli Situ
Quanyan Liang
Ziying Zeng
Jv Chen
Zheng Shao
Qinying Xu
Xiaoyong Lu
Yongshi Cui
Juying Zhang
Lingling Lu

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1089531

3,273 views
2 citations

Original Research

Published on 27 Jan 2023

Construction of a serum diagnostic signature based on m5C-related miRNAs for cancer detection

in Cancer Endocrinology

Fuzhou Tang
Yang Liu
Yichi Sun
Yu Xiong
Yan Gu
Jing Zhou
Yan Ouyang
Shichao Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1099703

2,028 views
1 citation

Editorial

Published on 27 Jan 2023

Editorial: DNA damage response pathways meet endocrine systems

in Cancer Endocrinology

Haim Werner
Leonard Girnita

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1138326

1,104 views

Review

Published on 26 Jan 2023

Lactate-related metabolic reprogramming and immune regulation in colorectal cancer

in Cancer Endocrinology

Qianhui Sun
Jingyuan Wu
Guanghui Zhu
Tingting Li
Xiaoyu Zhu
Baoyi Ni
Bowen Xu
Xinyi Ma
Jie Li

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1089918

7,106 views
4 citations

Editorial

Published on 23 Jan 2023

Editorial: New molecular targets involved in lung adenocarcinoma

in Cancer Endocrinology

Xianquan Zhan
Na Li

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1138849

1,348 views

Original Research

Published on 23 Jan 2023

Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer

in Cancer Endocrinology

Yuichiro Iwamoto
Tomohiko Kimura
Hideyuki Iwamoto
Junpei Sanada
Yoshiro Fushimi
Yukino Katakura
Fuminori Tatsumi
Masashi Shimoda
Shuhei Nakanishi
Tomoatsu Mune

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1079074

1,905 views
3 citations

Original Research

Published on 20 Jan 2023

Shared sex hormone metabolism-related gene prognostic index between breast and endometrial cancers

in Cancer Endocrinology

Junyi Duan
Chenan Liu
Jiahong Yi
Yun Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1126862

2,732 views

Original Research

Published on 20 Jan 2023

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors

in Cancer Endocrinology

Chiara Liverani
Chiara Spadazzi
Toni Ibrahim
Federica Pieri
Flavia Foca
Chiara Calabrese
Alessandro De Vita
Giacomo Miserocchi
Claudia Cocchi
Silvia Vanni

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1045038

2,796 views
2 citations

Original Research

Published on 20 Jan 2023

Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer

in Cancer Endocrinology

Biao Zhang
Qihang Yuan
Bolin Zhang
Shuang Li
Zhizhou Wang
Hangyu Liu
Fanyue Meng
Xu Chen
Dong Shang

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1078424

4,121 views
17 citations

Original Research

Published on 20 Jan 2023

A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer

in Cancer Endocrinology

Gouling Zhan
Jianbing Hu
Shijian Da
Jie Weng
Chuanyi Zhou
Fang Wen
Songlian Liu
Fang Fang
Erdong Shen
Qiang Zhou

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1110624

1,639 views
2 citations

Original Research

Published on 19 Jan 2023

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer

in Cancer Endocrinology

Weiyu Lu
Biao Xie
Guangqing Tan
Wanying Dai
Jingyi Ren
Sadaf Pervaz
Kun Li
Fangfang Li
Yingxiong Wang
Meijiao Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1088944

2,086 views
2 citations

Navigation group

Articles

Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation

A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort

A novel pyroptosis gene expression-based risk score for survival in gastric cancer

Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis

Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma

Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets

Construction of a serum diagnostic signature based on m5C-related miRNAs for cancer detection

Editorial: DNA damage response pathways meet endocrine systems

Lactate-related metabolic reprogramming and immune regulation in colorectal cancer

Editorial: New molecular targets involved in lung adenocarcinoma

Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer

Shared sex hormone metabolism-related gene prognostic index between breast and endometrial cancers

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors

Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer

A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer